Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Endoscopic screening for gastric cancer is cost effective in Asian Americans

Publish date:: September 14, 2020

Key clinical point: There are no current guidelines for gastric cancer screening.

Major finding: The incremental cost-effectiveness ratio was lowest for Chinese, Japanese, and Korean Americans, all with values below $73,748 per quality-adjusted life-year.

Study details: Computer model with output compared with the Surveillance, Epidemiology, and End Results database.

Disclosures: The study was supported by the Agency for Healthcare Research and Quality, Patient-Centered Outcomes Research Institute, the American Gastroenterological Association, and the Department of Veteran Affairs.

Citation:

Shah SC et al. Clin Gastroenterol Hepatol. 2020 July 21. doi: 10.1016/j.cgh.2020.07.031

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Gastroenterology

Younger adults present with more advanced esophageal adenocarcinoma,

DOACs look safe in elective endoscopic procedures,

Upper GI bleeds in COVID-19 not related to increased mortality,

Cryoballoon, cryospray found equivalent for eradicating Barret’s esophagus,